CardioTube Interview | Late-Breaking Trial - Paclitaxel-coated Balloon Versus Uncoated Balloon For Coronary In-stent Restenosis - Two-year Outcomes of the AGENT IDE Trial

Saturday, March 8, 2025

1:15 PM – 1:30 PM ET

Interviewee(s)

Jeffrey W. Moses, MD, FSCAI

John and Myrna Daniels Professor of Cardiology
Columbia University Medical Center
New York, New York, United States

Disclosure(s): Covanos Inc.: Stock-privately held company (Ongoing); Orchestra Biomed: Stock-privately held company (Ongoing); OSTIAL Corp: Stock-privately held company (Ongoing); Weightless Lead: Stock-privately held company (Ongoing); Xenter Inc: Stock-privately held company (Ongoing)

Interviewer(s)

Brian C. Case, MD

Interventional Cardiologist; Assistant Professor of Medicine, Georgetown University; Director of Cath Lab, Chief of Interventional Cardiology, MedStar Southern Maryland Hospital
MedStar Heart and Vascular Institute
Bethesda, Maryland, United States

Disclosure(s): Acist Medical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Philips Medical Systems, Inc.: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Disclosure(s):

Hector M. Garcia-Garcia, MD, PhD: Abbott Vascular, Medtronic, Boston Scientific: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)